140 related articles for article (PubMed ID: 16908173)
1. Synthesis and immunosuppressive activity of new artemisinin derivatives. Part 2: 2-[12(beta or alpha)-dihydroartemisinoxymethyl(or 1'-ethyl)]phenoxyl propionic acids and esters.
Yang ZS; Wang JX; Zhou Y; Zuo JP; Li Y
Bioorg Med Chem; 2006 Dec; 14(23):8043-9. PubMed ID: 16908173
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and immunosuppressive activity of new artemisinin derivatives. 1. [12(beta or alpha)-Dihydroartemisininoxy]phen(ox)yl aliphatic acids and esters.
Yang ZS; Zhou WL; Sui Y; Wang JX; Wu JM; Zhou Y; Zhang Y; He PL; Han JY; Tang W; Li Y; Zuo JP
J Med Chem; 2005 Jul; 48(14):4608-17. PubMed ID: 15999998
[TBL] [Abstract][Full Text] [Related]
3. [Synthesis and immunosuppressive activity of new artemisinin derivatives containing polyethylene glycol group].
Zhang JX; Wang JX; Zhang Y; Zuo JP; Wu JM; Sui Y; Li Y
Yao Xue Xue Bao; 2006 Jan; 41(1):65-70. PubMed ID: 16683530
[TBL] [Abstract][Full Text] [Related]
4. Suppressive effect of a novel water-soluble artemisinin derivative SM905 on T cell activation and proliferation in vitro and in vivo.
Wang JX; Tang W; Yang ZS; Wan J; Shi LP; Zhang Y; Zhou R; Ni J; Hou LF; Zhou Y; He PL; Yang YF; Li Y; Zuo JP
Eur J Pharmacol; 2007 Jun; 564(1-3):211-8. PubMed ID: 17349993
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and structure-immunosuppressive activity relationships of bakuchiol and its derivatives.
Chen H; Du X; Tang W; Zhou Y; Zuo J; Feng H; Li Y
Bioorg Med Chem; 2008 Mar; 16(5):2403-11. PubMed ID: 18063371
[TBL] [Abstract][Full Text] [Related]
6. Studies on the stereoselective synthesis and immunosuppressive activity of dihydroartemisinin-O-glycoside derivatives.
Yu Y; Yu J; Zou X; Xu W; Zhang J; Bian H; Dong X; Shen Z
Bioorg Med Chem Lett; 2020 Aug; 30(16):127338. PubMed ID: 32631539
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antiangiogenic activity of thioacetal artemisinin derivatives.
Oh S; Jeong IH; Ahn CM; Shin WS; Lee S
Bioorg Med Chem; 2004 Jul; 12(14):3783-90. PubMed ID: 15210144
[TBL] [Abstract][Full Text] [Related]
8. A novel artemisinin derivative, 3-(12-beta-artemisininoxy) phenoxyl succinic acid (SM735), mediates immunosuppressive effects in vitro and in vivo.
Zhou WL; Wu JM; Wu QL; Wang JX; Zhou Y; Zhou R; He PL; Li XY; Yang YF; Zhang Y; Li Y; Zuo JP
Acta Pharmacol Sin; 2005 Nov; 26(11):1352-8. PubMed ID: 16225758
[TBL] [Abstract][Full Text] [Related]
9. Artemisinin and its derivatives enhance T lymphocyte-mediated immune responses in normal mice and accelerate immunoreconstitution of mice with syngeneic bone marrow transplantation.
Yang SX; Xie SS; Gao HL; Long ZZ
Clin Immunol Immunopathol; 1993 Nov; 69(2):143-8. PubMed ID: 8403551
[TBL] [Abstract][Full Text] [Related]
10. Design and Synthesis of Marine Phidianidine Derivatives as Potential Immunosuppressive Agents.
Liu J; Li H; Chen KX; Zuo JP; Guo YW; Tang W; Li XW
J Med Chem; 2018 Dec; 61(24):11298-11308. PubMed ID: 30500185
[TBL] [Abstract][Full Text] [Related]
11. Orally active esters of dihydroartemisinin: Synthesis and antimalarial activity against multidrug-resistant Plasmodium yoelii in mice.
Singh C; Chaudhary S; Puri SK
Bioorg Med Chem Lett; 2008 Feb; 18(4):1436-41. PubMed ID: 18206370
[TBL] [Abstract][Full Text] [Related]
12. Investigation of the immunosuppressive activity of artemether on T-cell activation and proliferation.
Wang JX; Tang W; Shi LP; Wan J; Zhou R; Ni J; Fu YF; Yang YF; Li Y; Zuo JP
Br J Pharmacol; 2007 Mar; 150(5):652-61. PubMed ID: 17262016
[TBL] [Abstract][Full Text] [Related]
13. Dihydroartemisinin inhibits activation of the Toll-like receptor 4 signaling pathway and production of type I interferon in spleen cells from lupus-prone MRL/lpr mice.
Huang X; Xie Z; Liu F; Han C; Zhang D; Wang D; Bao X; Sun J; Wen C; Fan Y
Int Immunopharmacol; 2014 Sep; 22(1):266-72. PubMed ID: 25027631
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antiangiogenic activity of exo-olefinated deoxoartemisinin derivatives.
Oh S; Jeong IH; Shin WS; Lee S
Bioorg Med Chem Lett; 2004 Jul; 14(14):3683-6. PubMed ID: 15203143
[TBL] [Abstract][Full Text] [Related]
15. In vitro inhibition of Toxoplasma gondii by four new derivatives of artemisinin.
Jones-Brando L; D'Angelo J; Posner GH; Yolken R
Antimicrob Agents Chemother; 2006 Dec; 50(12):4206-8. PubMed ID: 17060514
[TBL] [Abstract][Full Text] [Related]
16. Growth inhibition activity of thioacetal artemisinin derivatives against human umbilical vein endothelial cells.
Oh S; Jeong IH; Shin WS; Lee S
Bioorg Med Chem Lett; 2003 Nov; 13(21):3665-8. PubMed ID: 14552753
[TBL] [Abstract][Full Text] [Related]
17. New immunosuppressive activity of dykellic acid.
Han SB; Lee HJ; Kho YH; Jeon YJ; Lee SH; Kim HC; Kim HM
J Antibiot (Tokyo); 2001 Oct; 54(10):840-3. PubMed ID: 11776441
[No Abstract] [Full Text] [Related]
18. Antiangiogenic activity of deoxoartemisinin derivatives on chorioallantoic membrane.
Jung M; Tak J; Chung WY; Park KK
Bioorg Med Chem Lett; 2006 Mar; 16(5):1227-30. PubMed ID: 16380253
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of mitogen-activated proliferation of human peripheral lymphocytes in vitro by propionic acid.
Wajner M; Santos KD; Schlottfeldt JL; Rocha MP; Wannmacher CM
Clin Sci (Lond); 1999 Jan; 96(1):99-103. PubMed ID: 9857112
[TBL] [Abstract][Full Text] [Related]
20. Antimalarial activity of new dihydroartemisinin derivatives. 6. alpha-Alkylbenzylic ethers.
Lin AJ; Miller RE
J Med Chem; 1995 Mar; 38(5):764-70. PubMed ID: 7877142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
